FDA Inspection 1272579 — Enrico Bertini MD
The FDA completed an inspection of Enrico Bertini MD on May 9, 2025 in Rome. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 9, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Rome (Italy)
Additional Details
Clinical Investigator (CI)